miRNAs play critical roles in various biological processes by targeting specific mRNAs. Current approaches to identifying miRNA targets are insufficient for elucidation of a miRNA regulatory network. Here, we created a cell-based screening system using a luciferase reporter library composed of 4,891 full-length cDNAs, each of which was integrated into the 3′ UTR of a luciferase gene. Using this reporter library system, we conducted a screening for targets of miR-34a, a tumor-suppressor miRNA. We identified both previously characterized and previously uncharacterized targets. miR-34a overexpression in MDA-MB-231 breast cancer cells repressed the expression of these previously unrecognized targets. Among these targets, GFRA3 is crucial for MDA-MB-231 cell growth, and its expression correlated with the overall survival of patients with breast cancer. Furthermore, GFRA3 was found to be directly regulated by miR-34a via its coding region. These data show that this system is useful for elucidating miRNA functions and networks.
miRNAs play critical roles in various biological processes by targeting specific mRNAs. Current approaches to identifying miRNA targets are insufficient for elucidation of a miRNA regulatory network. Here, we created a cell-based screening system using a luciferase reporter library composed of 4,891 full-length cDNAs, each of which was integrated into the 3′ UTR of a luciferase gene. Using this reporter library system, we conducted a screening for targets of miR-34a, a tumor-suppressor miRNA. We identified both previously characterized and previously uncharacterized targets. miR-34a overexpression in MDA-MB-231 breast cancer cells repressed the expression of these previously unrecognized targets. Among these targets, GFRA3 is crucial for MDA-MB-231 cell growth, and its expression correlated with the overall survival of patients with breast cancer. Furthermore, GFRA3 was found to be directly regulated by miR-34a via its coding region. These data show that this system is useful for elucidating miRNA functions and networks. Identification of miRNA targets often involves a combination of the following approaches: transcriptome analysis, in silico prediction tools, transcriptome-wide miRNA-mRNA interaction analysis, and cell-based screening systems. Transcriptome analysis, such as microarray or high-throughput RNA sequencing (RNAseq) with or without specific miRNAs, may find putative target transcripts whose stability is significantly decreased by the miRNA. However, the targets of the miRNA, which are regulated at the level of translation, may not always correspond to the protein levels (1) (2) (3) . Current computational tools for prediction of miRNA targets such as TargetScan (4) predict target candidates by miRNAmRNA sequence matches; however, these candidates have many false positives, and most information regarding the target regions from these prediction tools is restricted to the mRNA's 3′ UTR. Transcriptome-wide miRNA-mRNA interaction analysis, including RNA-binding protein immunoprecipitation-sequencing (RIP-seq) (5, 6) and high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation (HITS-CLIP) (7-10) using the Argonaute (Ago) protein, which is a major RISC component, enables global mapping of Ago-binding sequences. Sequencing of target transcripts captured by biotinylated miRNA mimics also has been reported (11) . However, the transcripts detected by these methods are not always functional targets. Finally, cell-based screening systems also have been reported. 3′LIFE, reported by Wolter et al., is a screening system for functional miRNA targets and is based on a luciferase reporter library of 275 human 3′ UTRs; this system sensitively identified the targets of let-7c and miR-10b (12, 13) . Recently, the same group reported a reporter library of a larger scale. They constructed a luciferase reporter library of 1,461 human 3′ UTRs, termed the "human 3′UTRome v1 clone collection" (h3′ UTRome v1), which consists of human 3′ UTRs from transcription factors, kinases, and RNA-binding proteins (14) . This system allows screening individual miRNAs without biasing the screen toward candidate genes identified bioinformatically, enabling the identification of genes targeted via noncanonical and poorly conserved interactions. On the other hand, the 3′-UTR library is not sufficiently large-scale, and the target region is restricted to the 3′ UTR.
To overcome this problem, we developed a luciferase assay-based target screening system. Using cDNAs from the Mammalian Gene Collection (MGC) plasmids and the Gateway recombination system, we constructed a reporter plasmid library in which the luciferase gene includes 4,891 nonbiased cDNA sequences in the 3′ UTR. Screening for miRNA targets was conducted by luciferase assays on the reporter library with or without an expression vector for the miRNA of interest. This system allows us to evaluate the putative direct targets of specific miRNAs functionally through its full-length sequence not only at the mRNA level but also at the protein level.
To verify this system, we focused on miR-34a and conducted a screening for its targets. miR-34a is a downstream miRNA of the Significance Identification of miRNA targets is necessary for understanding their functions; however, current approaches to screening for specific targets are inadequate. For example, most miRNA targetprediction tools only match the 3′-UTR sequence with the miRNA sequence. We created a screening system for miRNA targets using a reporter library of 4,891 full-length cDNAs inserted into the 3′ UTR of a luciferase gene. Using this system, we identified targets of tumor suppressor miR-34a. Among the identified targets, GFRA3, which is crucial for growth of breast cancer cells and affects the survival of patients with breast cancer, was directly regulated by miR-34a via the coding region. Our study shows the advantage of this full-length reporter library system in identifying functional targets of miRNAs.
tumor suppressor p53 (15) (16) (17) . Decreased expression of miR-34a has been reported in various cancers (18) (19) (20) , and miR-34a plays a critical role in cell-cycle arrest, apoptosis, senescence, and inhibition of the epithelial-mesenchymal transition (15, 16, (21) (22) (23) (24) , indicating that miR-34a is a crucial target of p53 because of its tumor-suppressor function. Although this p53-miR-34a axis is widely known, the above-mentioned potential functions of miR34a are not fully explained by our limited information regarding the downstream molecular network of miR-34a. Our successful application of the newly created reporter library screening assay systematically identified functional targets of miR-34a without a bias. In addition, our results showed that GFRA3, one of the newly identified targets of miR-34a, regulates the growth of breast cancer cells, and miR-34a regulates it directly via its coding region. These results suggest that this library system can be an important alternative and complementary approach to surveying miRNAdependent molecular networks and functions.
Results
Construction of the Reporter Library. To develop the screening system for identifying the targets of miRNAs, we created a reporter plasmid library. This reporter vector library, which consisted of 4,891 full-length cDNAs in the 3′ UTR of the luc2 gene, was constructed by BP Clonase recombination of pLuc2-KAP-ccdB ( Fig.  S1 A and C) and the MGC library (Fig. S2 ) or by inserting a PCRamplified cDNA into the multiple cloning site of pLuc2-KAP-MCS (Fig. S1B ). Cloned cDNAs ranged in size from 290 to 8,472 bp, with an average size of 2,154.3 bp (Dataset S1). The size distribution of the cloned reporter library cDNAs is shown in Fig. S3 . These plasmids were purified, and the concentrations were measured. They were diluted and dispensed into 384-well plates (Fig. S2 ) that then were used as assay plates. A miRNA expression vector was cotransfected with the reporter library in the assay plates, and targets were screened by measuring changes in luc2 reporter activity (Fig. 1) .
To confirm the functionality of these reporters, we first performed luciferase assays using an expression vector with miR-34a, a transcriptional target miRNA of p53 and a proposed tumor suppressor (25) , as well as reporters of its putative targets SIRT1 (Sirtuin 1), BCL2 (B-cell lymphoma 2), CDK6 (cyclin-dependent kinase 6), MYC (v-myc avian myelocytomatosis viral oncogene homolog), and CREB1 (cAMP-responsive element-binding protein 1) (20, 22, (25) (26) (27) (28) (29) (30) (31) . However, miR-34a repressed the luciferase activities of only the SIRT1 and BCL2 reporters; the CDK6, MYC, and CREB1 reporter activities were not repressed ( Fig. S4 A and C and Tables S1 and S3). We speculated that nonsense-mediated mRNA decay (NMD) was the cause. The function of NMD is to reduce errors in gene expression by eliminating mRNA transcripts that contain premature termination codons (PTCs) (Fig. S5) (32, 33) . In addition, the length of the 3′ UTR influences the NMD pathway. A number of studies have revealed that artificial 3′ UTRs 800-900 bp in length promote NMD (34) (35) (36) (37) (38) (39) (40) (41) . The average length of the 3′ UTRs in our reporters is more than 2,000 bp, suggesting that the reporters may be affected by NMD, which would decrease observable changes in the reporter activities under the influence of miRNA. We first performed a luciferase assay using known miR34a target reporters with two siRNAs for UPF1, the central component of the NMD pathway (33) . The luciferase activities of the MYC and CREB1 reporters were decreased by miR-34a when UPF1 was knocked down (red boxes in Fig. S4 A and B and Tables  S1 and S2 ). Furthermore, we performed luciferase assays with an NMD inhibitor. SMG1, a phosphoinositide 3-kinase-like kinase, phosphorylates UPF1, and this phosphorylation is crucial for NMD (33) . Wortmannin is an inhibitor of the kinase SMG1 and thus inhibits NMD (Fig. S5) (42, 43) . The rescue effect seen with the UPF1 knockdown also was detected using wortmannin ( Fig. S4 C and D and Table S3 ). These data suggest that screening (miR-34a) or empty vector (Ctrl). *P < 0.05, **P < 0.01, ***P < 0.001.
of targets of miRNA with an NMD inhibitor can increase assay sensitivity.
A Cell-Based Screening System Using the Reporter Library-Identified miRNA Targets. To evaluate the reporter library system with the NMD inhibitor wortmannin, we conducted a screening for potential targets of miR-34a. The screening procedure is shown in Fig. 2A .
As a result, we identified eight reported miR-34a targets (SIRT1, SEMA4B, BCL2, MYB, CREB1, CSF1R, MYC, and REF1) (20, (44) (45) (46) (47) (48) and four previously unreported miR-34a targets (FAM76A, GFRA3, CARKL, and REM2) (Fig. 2B) . Reporters of FAM76A (family with sequence similarity 76, member A) and GFRA3 (glial cell line-derived neurotrophic factor family receptor alpha 3) were significantly inhibited by miR-34a (Fig. 2B) . We next searched for miR-34a target sites in these identified transcripts using TargetScan, a miRNA target prediction tool (www.targetscan.org/vert_71/) (4). BCL2, CSF1R, SEMA4B, LEF1, and FAM76A have conserved miR-34a target sites, whereas SIRT1, MYB, CREB1, and GFRA3 have poorly conserved miR-34a target sites in their 3′ UTRs (Fig.  S6 ). Other target candidates (MYC, CARKL, and REM2) did not have TargetScan-predicted miR-34a target sites, suggesting that this reporter system may identify miRNA targets not found by miRNA target-prediction tools. In addition, we investigated the expression of these previously unidentified target candidates in miR-34a-overexpressing MDA-MB-231 human breast cancer cells. The mRNA levels of FAM76A and GFRA3 were repressed by the overexpression of a miR-34a mimic in MDA-MB-231 cells, but mRNA levels of CARKL and REM2 were not significantly changed compared with the negative control (Fig. 2C) . In addition, the mRNA expression of SEMA4B, CREB1, and MYC was not reduced by miR-34a overexpression, although other identified targets (SIRT1, BCL2, MYB, CSF1R, and LEF1) were downregulated (Fig. S7) . However, protein levels of FAM76A, GFRA3, CARKL, and REM2 were reduced in miR-34a-overexpressing MDA-MB-231 cells (Fig. 2 D and E) . These data indicate that miR-34a regulates the expression of these four target candidates and suggest that this system can identify the targets of the miRNA that are regulated at the level of translation. We next carried out luciferase assays with fragmented reporters. Although the reporters of FAM76A and REM2 were regulated by miR-34a via their 3′ UTR, the reporters of GFRA3 and CARKL were regulated via their coding region (Fig. 2F) , highlighting the significance of reporters containing whole-length cDNA sequences. Our system identified 12 targets of miR-34a, and two of these targets (16.7%) were regulated by miR-34a via their coding region. Furthermore, we used our system for screening with miR-146a, a miRNA crucial for inflammation, and identified six previously unreported miR-146a target candidates (RABL2B, CABLES1, TSCOT, BMP5, TM4SF19, and ABHD5) as well as the previously reported targets TRAF6, IRAK1, and CXCR4 (Fig. S8) , suggesting that the reporter library system is useful for screening the targets of various miRNAs.
GFRA3 Was Directly Regulated by miR-34a via Its Coding Region. To determine whether these identified targets were directly regulated by miR-34a, we focused on FAM76A and GFRA3, whose reporters were significantly down-regulated by miR-34a, and performed a reporter assay using various fragmented and point-mutated reporters. Reporters for the 3′ UTRs and for the whole inserted cDNAs of FAM76A were repressed by miR-34a (Figs. 2F and 3 A  and B) , and the repression of the reporter activity of the 3′ UTR FAM76A reporter by miR-34a was reversed when its predicted target sites were mutated (Fig. 3 A and B) . These data indicate that FAM76A was directly regulated by miR-34a via its 3′ UTR. In contrast, the activity of the GFRA3 reporter including only the coding region was repressed by miR-34a induction (Fig. 2F) . To test whether GFRA3 was directly regulated by miR-34a in its coding region, target candidate sites of miR-34a in the GFRA3 coding region were searched. As a result, three sites that are perfectly consistent with the complementary seed sequence of miR34a were found in the GFRA3 coding region (Fig. 3C) . Of note, these sequences were present in each of the three GDNF (glial cell line-derived neurotrophic factor) domains and located near this domain (between α-helix 2 and α-helix 3) (Fig. S9) . Reporter assays using a GFRA3 coding-region reporter with point mutations without amino acid sequence changes in the miR-34a target candidate sites revealed that these three sites were direct target sequences of miR-34a (Fig. 3D ). In addition, Western blot analysis using expression vectors of FLAG-tagged GFRA3 with or without point mutations in target sequences showed that FLAG-GFRA3 was repressed by miR-34a, but the repression by miR-34a was reversed in mutated FLAG-GFRA3 (Fig. 3E) . Furthermore, we performed AGO2-CLIP analysis in miR-34a mimic-overexpressing or negative control miRNA mimic-overexpressing MDA-MB-231 cells. Target mRNA sequences of FAM76A and GFRA3 were more concentrated in AGO2-binding mRNAs when miR-34a was overexpressed (Fig. S10) , indicating that miR-34a directly binds FAM76A and GFRA3 mRNAs. These data indicate that miR-34a directly regulates GFRA3 expression via these three target sequences in its coding region.
GFRA3 Regulates the Growth of MDA-MB-231 Breast Cancer Cells.
miR-34a, which is a known tumor suppressor, represses the growth of tumor cells, including breast cancer cells. To test whether these newly identified targets are important for the function of miR-34a, we analyzed the impact of the knockdown of target genes on the growth of MDA-MB-231 breast cancer cells. The knockdown of FAM76A and GFRA3 was successfully implemented using two independent siRNAs of each gene (Fig. S11) . A cell-viability assay using the RealTime-Glo MT Cell Viability Assay (Promega) in MDA-MB-231 cells transfected with the miR-34a mimic indicated that cell viability was reduced by overexpression of the miR-34a mimic, as previously reported (Fig. 4A) (19) . Cell viability was reduced in MDA-MB-231 cells in which the activity of GFRA3 was reduced by two siRNAs (Fig. 4A ). In addition, the knockdown of GFRA3, but not FAM76A, led to a significant decrease in the ability of MDA-MB-231 cells to form colonies (Fig. 4 B and C) . These data show that although FAM76A is not necessary for the growth of MDA-MB-231 breast cancer cells, GFRA3 is an important target of miR-34a function in tumor growth suppression.
Expression Analysis of GFRA3 and miR-34a in Breast Cancer. We found that GFRA3, a direct target of miR-34a, regulates the growth of breast cancer cells. A recent study showed that GFRA3 expression is significantly associated with survival in patients with breast cancer (49) . In addition, miR-34a expression negatively correlates with tumor grades and stages (19) . These results suggest that GFRA3 expression negatively correlates with miR-34a expression in breast cancer. Initially, we analyzed the expression of GFRA3 in breast cancer tissues and found that GFRA3 expression correlated with the overall survival (OS) of breast cancer patients (Fig. 5A) . Next, we analyzed the relation between miR-34a and GFRA3 expression. The expression of GFRA3 tended to be higher in breast cancer tissues with weaker miR-34a expression than in tissues with stronger miR-34a expression (Fig. 5B ). In addition, we analyzed the relation between expression levels of miR-34a and GFRA3 mRNA only in GFRA3 + breast cancer tissues. The GFRA3 expression levels were found to have a significant negative correlation with miR-34a expression according to Spearman's rank correlation test (Spearman's ρ −0.2242, P = 0.0273), although overall samples did not correlate (Spearman's ρ −0.1024, P = 0.1667) (Fig. S12) . These data suggest that the targeting of GFRA3 by miR-34a is an important component of its tumor-suppressor function.
Discussion
We constructed a reporter plasmid library that includes 4,891 cDNAs in the 3′-UTR region of a luciferase gene and used this library to screen for targets of a miRNA. By means of this system, we identified three previously unidentified target genes of miR-34a. Generally, two major miRNA-dependent regulatory mechanisms repress target mRNA expression: induction of mRNA instability or inhibition of the translation of protein from mRNA. To identify miRNA target mRNAs that are regulated by mRNA instability, transcriptome analysis in loss-or gain-offunction experiments combined with other approaches such as in silico prediction tools or genome-wide direct interaction analysis by pull-down methods are useful; however, the targets of miRNA that are regulated at the translational level are difficult to survey. Our data indicate that CARKL and REM2 expression levels were decreased at the protein level by induction of a miR34a mimic in MDA-MB-231 cells but were not reduced at the mRNA level (Fig. 2 C-E) . In addition, miR-146a, which is induced by NFκB and acts as a negative feedback regulator of the innate immune response by targeting two adapter proteins, TRAF6 (TNF receptor-associated factor 6) and IRAK1 (IL-1 receptorassociated kinase 1) (50), regulates its targets mainly at the level of translation. The protein levels of TRAF6 and IRAK1 are markedly increased in miR-146a-knockout macrophages compared with wild-type macrophages, but the expression of TRAF6 and IRAK1 genes is not affected at the mRNA level (51) . These data indicate that our system is useful for the identification of miRNA targets not only at the mRNA stability level but also at the translation level.
We established that GFRA3 is directly regulated by miR-34a via binding in its coding region. miRNA target-prediction tools such as TargetScan search for sequence matches between miRNA seed sequences and 3′-UTR sequences. Here, we identified a target that did not match any target prediction algorithms.
Although it is believed that miRNAs mostly recognize the 3′ UTR of targeted mRNAs, a recent unbiased study on the identification of target regions of mRNAs at the transcriptome level (by CLIP analysis) revealed that the coding region of mRNA could be targeted physically by a miRNA-containing RISC complex (7) (8) (9) 52) . In this regard, several miRNAs have been shown to regulate target mRNAs via their coding regions (53) (54) (55) (56) . In these reports, miRNA-dependent regulation via a coding region has been proved by endogenous expression changes caused by miRNA and a reporter assay using a reporter with a point mutation. We also tested to confirm the regulation of GFRA3 by miR-34a via its coding region by endogenous expression changes caused by miR-34a overexpression and luciferase assays using GFRA3-CDS reporters with point mutations for miR-34a targeting sites in this study. In addition, we found that target mRNA sequences of GFRA3 were more concentrated in AGO2-binding mRNAs when miR-34a was overexpressed, indicating that miR-34a directly binds GFRA3 mRNAs (Fig.  S10) . These data strongly indicate the coding region-mediated direct regulation of GFRA3 by miR-34a. In addition, transcriptome-wide mRNA-miRNA mapping analyses, such as AGO-CLIP, revealed that the largest proportion (20-50%) of clusters is present in both 3′ UTRs and coding regions (7-9, 52), suggesting that miRNA targets that are regulated via their coding sequence (CDS) may abound.
GFRA3 is an artemin receptor, which is a growth factor belonging to the GDNF family (57) . The artemin-GFRA3 axis is important for a diverse range of physiological functions including the development and maintenance of various neuronal populations (58), neurite outgrowth (59), and nerve regeneration (60, 61) . The artemin-GFRA3 axis is also important for tumor development. GFRA3 expression is significantly associated with the survival outcomes of patients with breast cancer, and coexpression of artemin with GFRA3 produces a synergistic increase in the odds ratio for both relapse-free and OS (49) . We showed a significant association between GFRA3 expression and OS in patients with breast cancer (Fig. 5A) . In addition, a knockdown of GFRA3 in MDA-MB-231 breast cancer cells inhibited the growth of the cells; similarly, overexpression of miR-34a reduced cell growth (Fig. 4 A-C) . These data suggest that the inhibition of breast cancer growth by miR-34a was caused, at least in part, by the down-regulation of GFRA3.
Thus, our screening for the targets of miR-34a using a newly prepared reporter library system revealed functional and systematic direct targets of miR-34a, including GFRA3, whose target region is located in its CDS. We also showed that the newly identified p53→miR-34a→GFRA3 molecular axis has tumor-suppressive functions in breast cancer. These data indicate that the reporter library system is useful for identifying functional targets of miRNAs in various regions in the targets and at various posttranscriptional stages. This method also should be applicable to the search for functional targets of specific RNA-binding proteins. Application of this strategy should accelerate the research into miRNAdependent biology and pathologies and may uncover new rules of gene-expression regulation at posttranscriptional levels.
Methods
Two hundred samples of breast carcinomas from 2003-2008 for the mRNA assay came from the archive of the Department of Breast and Endocrine Surgery, Nagoya City University Hospital, Nagoya, Japan. Informed consent for the use of these samples had been obtained at the time of the surgical procedure. This protocol was approved by the Institutional Review Board of Nagoya City University Graduate School of Medical Sciences and conformed to the guidelines of the Declaration of Helsinki.
Cell-based screening for the targets of miRNAs using a reporter library was performed by modifying a previously described method (62) . Five microliters of OPTI-MEM containing 0.15 μL of FuGENE HD (Promega), 20 ng of pcDNAmiR-34a, pcDNA-miR-146a, or pcDNA3.1(+), and 5 ng of pRL-SV40 (Promega) Renilla luciferase construct was added to the 384-well reporter library plates and incubated for 20 min. Then 293FT cells (Invitrogen) in 40 μL of DMEM containing 10% of FBS were added into each well using an automated multidispenser ECO DROPPER III (AS ONE). The cells were cultured in a 5% CO 2 incubator at 37°C for 24 h. Then 5 μL of the culture medium with or without 0.5 nL of 1 mM wortmannin (Sigma) stock solution, which was diluted in DMSO, was added into each well (final concentration 100 nM). The cells were cultured in a 5% CO 2 incubator at 37°C for 5 h. Luciferase activity was measured by means of an ARVO X3 (PerkinElmer) and the Dual-Glo Luciferase Assay System (Promega). Overviews of the system and procedure are shown in Fig. 1A and Fig. S13 .
For additional information on methods, see SI Materials and Methods.
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